2135.HK Stock Analysis
21
Uncovered
Raily Aesthetic Medicine International Holdings Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Raily Aesthetic Medicine International Holdings Ltd. is an investment holding company, which engages in the provision of aesthetic medical services and consulting services. The company is headquartered in Hangzhou, Zhejiang and currently employs 382 full-time employees. The company went IPO on 2020-12-28. The firm mainly operates through two segments. The Aesthetic Medical Services segment mainly includes inpatient services, including surgical services and outpatient services (including injection service, dermatology service and others). The Consulting Services segment principally includes management consulting services and aesthetic training courses. The firm mainly conducts business within the domestic market.